Compare · HTFL vs MDLN
HTFL vs MDLN
Side-by-side comparison of Heartflow Inc. (HTFL) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HTFL and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 18.1x HTFL ($2.45B).
- Over the past year, HTFL is down 4.9% and MDLN is down 17.1% - HTFL leads by 12.2 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 1 for HTFL).
- MDLN has more recent analyst coverage (25 ratings vs 7 for HTFL).
PerformanceHTFL+8.45%MDLN-17.07%
2025-12-17+0.00%2026-06-08
- Company
- Heartflow Inc.
- Medline Inc.
- Price
- $28.43+1.23%
- $33.80+0.58%
- Market cap
- $2.45B
- $44.40B
- 1M return
- -5.12%
- -19.55%
- 1Y return
- -4.90%
- -17.07%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 1
- 20
- Recent ratings
- 7
- 25
Latest HTFL
- Chief Medical Officer Rogers Campbell exercised 9,219 shares at a strike of $19.00 and sold $261,266 worth of shares (9,219 units at $28.34) as part of a pre-agreed trading plan (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Heartflow Inc.
- SEC Form 10-Q filed by Heartflow Inc.
- Heartflow Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
- Chief Executive Officer Farquhar John C.M. sold $657,005 worth of shares (22,562 units at $29.12) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 519,397 units (SEC Form 4)
- A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
- The Future of Intoxication Detection May Be in Your Voice
- Chief Accounting Officer Jones Marie L. covered exercise/tax liability with 567 units of Common Stock., decreasing direct ownership by 2% to 31,083 units (SEC Form 4) (withholding tax)
- Chief Medical Officer Rogers Campbell covered exercise/tax liability with 2,271 shares, decreasing direct ownership by 3% to 78,731 units (SEC Form 4) (withholding obligation)
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)